INNT 110% Opportunity Over 1 month

4 เม.ย. 2018

I've had this position open for a while now but figured there's still enough upside to share. They're currently in phase 3 development of the only drug candidate to treat celiac disease. That's the one where people can't eat gluten, an allergy everyone suddenly seems to be afflicted with these days. It is a chronic disorder for those who really have it, meaning life-long treatment with the drug since right now the only course of treatment is to stay away from food that contains wheat, which is basically just about everything. Bull run will drive this up to the targets. Target two is a reasonable price for a drug with this wide of a range, so we could see an even higher drive up. This is one of those, don't get too greedy situations I think.

4 เม.ย. 2018

การซื้อขายยังคงดำเนินอยู่